Safety and Efficacy of Metformin for Treatment of Cytopenia in Children and Adolescents With Fanconi Anemia

PHASE3RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 5, 2022

Primary Completion Date

October 31, 2024

Study Completion Date

March 31, 2025

Conditions
Fanconi Anemia
Interventions
DRUG

Metformin

Patients will receive metformin immediate-release tablets orally for 24 weeks. Starting dose will be 500 mg once daily for all patients and the dose will be increased by 500 mg weekly until the goal dose is achieved (500 mg twice daily for patients \< 10 years of age, and 1000 mg twice daily for patients 10 years or older)

Trial Locations (2)

11566

RECRUITING

Ain Shams University, Cairo

Unknown

RECRUITING

University of Alexandria, Alexandria

All Listed Sponsors
lead

Ain Shams University

OTHER